688068 热景生物
2024/03 - 三个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额(14,007)(51,949)978,7532,644,482164,624
投资活动产生之现金流量净额63,266(161,867)(1,130,052)(1,762,893)(164,098)
筹资活动产生之现金流量净额(86,960)(36,547)(484,987)(95,069)(42,162)
汇率变动对现金及现金等价物的影响(78)(465)5,198(14,833)1,403
现金及现金等价物净增加/(减少)(37,780)(250,828)(631,088)771,688(40,234)
期初现金及现金等价物余额272,387523,2151,154,302382,615422,849
期末现金及现金等价物余额234,607272,387523,2151,154,302382,615